KILITCH DRUGS (INDIA)
Quarterly Results Analysis [Sep2024]
KILITCH DRUGS (INDIA) Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹47 Cr | ₹33 Cr | ₹45 Cr | ₹32 Cr | ₹41 Cr | ₹37 Cr | ₹45 Cr | ₹30 Cr |
Expenses | ₹41 Cr | ₹32 Cr | ₹38 Cr | ₹30 Cr | ₹33 Cr | ₹30 Cr | ₹39 Cr | ₹26 Cr |
Operating Income | ₹6 Cr | ₹2 Cr | ₹7 Cr | ₹2 Cr | ₹9 Cr | ₹6 Cr | ₹6 Cr | ₹4 Cr |
Other Income | ₹5 Cr | ₹3 Cr | ₹0 Cr | ₹3 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Interest | ₹0 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹10 Cr | ₹2 Cr | ₹5 Cr | ₹3 Cr | ₹7 Cr | ₹4 Cr | ₹5 Cr | ₹2 Cr |
Profit After Tax | ₹9 Cr | ₹0 Cr | ₹4 Cr | ₹2 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
EPS | ₹5.36 | ₹0.83 | ₹2.23 | ₹1.81 | ₹2.95 | ₹2.15 | ₹2.29 | ₹1.52 |
Industry Peers & Returns | 1W | 1M | 1Y |
KILITCH DRUGS (INDIA) | -2% | 1.6% | -12.6% |
SUN PHARMACEUTICAL INDUSTRIES | 3.7% | 8.5% | 49.4% |
CIPLA | 3% | 1.9% | 20.9% |
DR REDDYS LABORATORIES | 2.7% | 15.5% | 23.2% |
ZYDUS LIFESCIENCES | -1.6% | 1% | 43.9% |
DIVIS LABORATORIES | 3.6% | 1.8% | 52.1% |
MANKIND PHARMA | -4.9% | 11.4% | 49.2% |
TORRENT PHARMACEUTICALS | -1.4% | 5.3% | 49.3% |
LUPIN | 6.9% | 15.6% | 73.7% |
KILITCH DRUGS (INDIA) Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 41.92 % |
Y-o-Y | 15.22 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹47 Cr | 41.92 | |
Jun2024 | ₹33 Cr | -25.36 | |
Mar2024 | ₹45 Cr | 40.97 | |
Dec2023 | ₹32 Cr | -22.83 | |
Sep2023 | ₹41 Cr | 12.71 | |
Jun2023 | ₹37 Cr | -19.61 | |
Mar2023 | ₹45 Cr | 51.73 | |
Dec2022 | ₹30 Cr | - |
KILITCH DRUGS (INDIA) Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 267.05 % |
Y-o-Y | -29.31 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹6 Cr | 267.05 | |
Jun2024 | ₹2 Cr | -76.55 | |
Mar2024 | ₹7 Cr | 210.57 | |
Dec2023 | ₹2 Cr | -73.56 | |
Sep2023 | ₹9 Cr | 39.49 | |
Jun2023 | ₹6 Cr | -0.55 | |
Mar2023 | ₹6 Cr | 56.11 | |
Dec2022 | ₹4 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 158.67 % |
Y-o-Y | -38.67 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 12.83% | 158.67 | |
Jun2024 | 4.96% | -68.59 | |
Mar2024 | 15.79% | 120.22 | |
Dec2023 | 7.17% | -65.73 | |
Sep2023 | 20.92% | 23.79 | |
Jun2023 | 16.9% | 23.72 | |
Mar2023 | 13.66% | 2.86 | |
Dec2022 | 13.28% | - |
KILITCH DRUGS (INDIA) Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 7,589.29 % |
Y-o-Y | 69.09 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹9 Cr | 7,589.29 | |
Jun2024 | ₹0 Cr | -96.96 | |
Mar2024 | ₹4 Cr | 111.37 | |
Dec2023 | ₹2 Cr | -65.80 | |
Sep2023 | ₹5 Cr | 66.38 | |
Jun2023 | ₹3 Cr | 5.52 | |
Mar2023 | ₹3 Cr | 69.85 | |
Dec2022 | ₹2 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 5,396.97 % |
Y-o-Y | 46.76 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 18.14 % | 5,396.97 | |
Jun2024 | 0.33 % | -95.99 | |
Mar2024 | 8.22 % | 50.00 | |
Dec2023 | 5.48 % | -55.66 | |
Sep2023 | 12.36 % | 47.67 | |
Jun2023 | 8.37 % | 31.19 | |
Mar2023 | 6.38 % | 11.93 | |
Dec2022 | 5.7 % | - |
KILITCH DRUGS (INDIA) Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 545.78 % |
Y-o-Y | 81.69 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹5.36 | 545.78 | |
Jun2024 | ₹0.83 | -62.78 | |
Mar2024 | ₹2.23 | 23.20 | |
Dec2023 | ₹1.81 | -38.64 | |
Sep2023 | ₹2.95 | 37.21 | |
Jun2023 | ₹2.15 | -6.11 | |
Mar2023 | ₹2.29 | 50.66 | |
Dec2022 | ₹1.52 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD